As of May 2024 Fulgent Genetics has a market cap of $0.63 Billion. This makes Fulgent Genetics the world's 5720th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.63 B | -25.7% |
2023 | $0.85 B | -4.82% |
2022 | $0.90 B | -70% |
2021 | $3.00 B | 104.4% |
2020 | $1.46 B | 429.74% |
2019 | $0.27 B | 381.09% |
2018 | $57.6 M | -26.21% |
2017 | $78.06 M | -61.83% |
2016 | $0.20 B |
On May 8th, 2024 the market cap of Fulgent Genetics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | $20.74 M | -96.74% | ๐บ๐ธ USA |
Philips PHG | $24.21 B | 3,704.11% | ๐ณ๐ฑ Netherlands |